Stock ATHJF PERCHERON THERAPEUTICS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Percheron Therapeutics Limited OTC Markets

Equities

ATHJF

AU0000317281

Delayed OTC Markets
Other stock markets
 11:09:57 2024-05-31 EDT 		5-day change 1st Jan Change
0.012 USD -84.00% Intraday chart for Percheron Therapeutics Limited -.--% +20.00%
06-17 Percheron Therapeutics Appoints CFO MT
06-03 Percheron Therapeutics Names Chief Medical Advisor MT

Chart calendar Percheron Therapeutics Limited

32.gaL-P9WV_o8W28RDx3KF34T4j3pxxthX9drpSn1O3E4.tMGneLz2j7Ylq_QwhAHgkN6K9Q4FrZ0xpaO4DToXnRrokZVvjPrGyXeenQ~e0f4a1a42ce3699e1d420d3e8655df5e

Upcoming events on Percheron Therapeutics Limited

2024-08-27 Q4 2024 Earnings Release (Projected)
2025-02-25 Q2 2025 Earnings Release (Projected)
2025-08-26 Q4 2025 Earnings Release (Projected)
2026-03-03 Q2 2026 Earnings Release (Projected)

Past events on Percheron Therapeutics Limited

2024-06-02 Bio International Convention
2024-04-29 18:53 March 2024 Sales and Revenue Release - Activities Report
2024-03-02 Muscular Dystrophy Association Clinical and Scientific Conference - Poster No - V410
2024-03-02 Muscular Dystrophy Association Clinical and Scientific Conference - Poster No - V409
2024-03-02 Muscular Dystrophy Association Clinical and Scientific Conference - Poster No - M149
2024-02-28 01:20 Q2 2024 Earnings Release
2024-01-30 17:12 December 2023 Sales and Revenue Release - Activities Report
2024-01-07 JPMorgan Healthcare Conference
2024-01-07 Biotech Showcase
2023-11-14 22:00 Annual General Meeting
2023-10-31 AusBiotech Conference
2023-10-30 18:38 September 2023 Sales and Revenue Release - Activities Report
2023-10-17 16:45 BIO Investor Forum
2023-09-08 00:00 ShareCafe Small Cap Hidden Gems Conference
2023-08-25 04:08 Q4 2023 Earnings Release
2023-07-27 19:37 June 2023 Sales and Revenue Release - Activities Report
2023-04-16 19:38 March 2023 Sales and Revenue Release - Activities Report
2023-02-22 00:24 Interim 2023 Earnings Release
2023-01-24 December 2022 Sales and Revenue Release - Activities Report
2022-11-16 22:00 Annual General Meeting

Annual results

Fiscal PeriodJune 2020 2021 2022 2023 2024
Net sales
Million AUD		Released
Forecast
Spread 		0,77


0,64
6,30
-89.89%		1,81
1,40
29.41%		1,96
1,80
9.15%
3,60

EBITDA
Million AUD		Released
Forecast
Spread 		0,00


-7,95
-8,88
10.49%		-5,71
-11,3
49.31%		-11,3
-12,1
7.07%
-13,2

EBIT
Million AUD		Released
Forecast
Spread 		0,00


-8,05
-8,87
9.28%		-5,80
-11,3
48.6%		-11,4
-12,2
6.66%
-13,3

Earnings before Tax (EBT)
Million AUD		Released
Forecast
Spread 		0,00


-8,06
-8,20
1.7%		0,00
0,00
- 		-11,4
-8,80
-29.32%
-17,2

Net income
Million AUD		Released
Forecast
Spread 		0,00


-8,06
-8,96
10.02%		0,00
0,00
- 		-11,4
-11,9
4.72%
-13,1

EPS
AUD		Released
Forecast
Spread 		0,00


-0,01
-0,02
6.88%		0,00
0,00
- 		-0,02
-0,02
4.39%
-0,02

Announcement Date26/08/2025/08/2131/08/2225/08/23-

Quarterly results

Fiscal PeriodJune 2021 S2 2024 S1
Net sales
Million AUD		Released
Forecast
Spread


1,20
0,00
-
EBITDA
Million AUD		Released
Forecast
Spread 		-6,01
-6,00
-0.17%		-4,69
-8,50
44.78%
EBIT
Million AUD		Released
Forecast
Spread 		-6,01
-6,00
-0.17%		-4,74
-8,50
44.23%
Net income
Million AUD		Released
Forecast
Spread


-4,74
-8,60
44.85%
EPS
AUD		Released
Forecast
Spread


-0,01
-0,01
40%
Announcement Date25/08/2128/02/24

Upcoming sector events for Percheron Therapeutics Limited

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Percheron Therapeutics Limited

2024-06-05 03:51 PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
2024-05-17 07:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
2024-05-15 08:05 THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-14 16:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 16:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PER Stock
  4. ATHJF Stock
  5. Calendar Percheron Therapeutics Limited